These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9802622)

  • 1. Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis.
    Oberhoff C; Szymeczek J; Hoffmann O; Winkler UH; Kaiser S; Schindler AE
    Breast Cancer Res Treat; 1998 Jul; 50(1):73-81. PubMed ID: 9802622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of tamoxifen on plasma coagulation and serous fibrinolysis.
    Jankowski J; Ramlau C; Kopczynski Z; Boryska M
    Eur J Gynaecol Oncol; 1993; 14 Suppl():155-8. PubMed ID: 8200368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tamoxifen on measurements of hemostasis in healthy women.
    Mannucci PM; Bettega D; Chantarangkul V; Tripodi A; Sacchini V; Veronesi U
    Arch Intern Med; 1996 Sep; 156(16):1806-10. PubMed ID: 8790074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
    Scarabin PY; Alhenc-Gelas M; Plu-Bureau G; Taisne P; Agher R; Aiach M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer.
    Oberhoff C; Hoffmann O; Winkler UH; Schindler AE
    Gynecol Endocrinol; 2001 Oct; 15(5):341-8. PubMed ID: 11727356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy.
    Rella C; Coviello M; Giotta F; Maiello E; Colavito P; Colangelo D; Quaranta M; Colucci G; Schittulli F
    Breast Cancer Res Treat; 1996; 40(2):151-9. PubMed ID: 8879681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis.
    Teede HJ; McGrath BP; Smolich JJ; Malan E; Kotsopoulos D; Liang YL; Peverill RE
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1404-9. PubMed ID: 10807761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.
    Tormey DC; Gray R; Falkson HC
    J Natl Cancer Inst; 1996 Dec; 88(24):1828-33. PubMed ID: 8961972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH; Schindler AE; Endrikat J; Düsterberg B
    Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature.
    Cosman F; Baz-Hecht M; Cushman M; Vardy MD; Cruz JD; Nieves JW; Zion M; Lindsay R
    Thromb Res; 2005; 116(1):1-13. PubMed ID: 15850603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adjuvant CMF chemotherapy in patients with breast cancer--results on blood coagulation and fibrinolysis].
    Oberhoff C; Winkler UH; Tauchert AM; Schindler AE
    Zentralbl Gynakol; 1997; 119(5):211-7. PubMed ID: 9281254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage II breast cancer patients.
    Pectasides D; Tsavdaridis D; Aggouridaki C; Tsavdaridou V; Visvikis A; Tsatalas K; Fountzilas G
    Anticancer Res; 1999; 19(4C):3521-6. PubMed ID: 10629646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR; Sidelmann J; Skouby SO; Jespersen J
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer. FNCLCC].
    Mauriac L; Blanc-Vincent MP; Luporsi E; Cutuli B; Fourquet A; Garbay JR; Giard S; Spyratos F; Zafrani B; Dilhuydy JM
    Bull Cancer; 2000 Jun; 87(6):469-90. PubMed ID: 10903789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chemoendocrine therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer. Japan Advanced Breast Cancer Study Group and Japan Clinical Oncology Group.
    ;
    Jpn J Cancer Res; 1993 Apr; 84(4):455-61. PubMed ID: 8514613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.
    Gelber RD; Cole BF; Goldhirsch A; Rose C; Fisher B; Osborne CK; Boccardo F; Gray R; Gordon NH; Bengtsson NO; Sevelda P
    Lancet; 1996 Apr; 347(9008):1066-71. PubMed ID: 8602056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Femoral fractures in postmenopausal breast cancer patients treated with adjuvant tamoxifen.
    Kristensen B; Ejlertsen B; Mouridsen HT; Andersen KW; Lauritzen JB
    Breast Cancer Res Treat; 1996; 39(3):321-6. PubMed ID: 8877012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?
    Erman M; Abali H; Oran B; Haznedaroglu IC; Canpinar H; Kirazli S; Celik I
    Ann Oncol; 2004 Nov; 15(11):1622-6. PubMed ID: 15520062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.